Hjem › Crohns sykdom › Washington › Tacoma
Kliniske studier for Crohns sykdom i Tacoma, WA
11 studier for Crohns sykdom søker deltakere på steder i og rundt Tacoma (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekruttererFase 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RekruttererFase 3
- Washington Gastroenterology - Tacoma ( Site 5004), Tacoma
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RekruttererFase 2
- Washington Gastroenterology - Tacoma /ID# 267302, Tacoma
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 2/3
- GI Alliance Tacoma, Tacoma
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekruttererFase 3
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RekruttererFase 4
- Washington Gastroenterology- GIA, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
RekruttererFase 3
- GI Alliance Tacoma, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
RekruttererFase 3
- MultiCare Institute for Research & Innovation, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RekruttererFase 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekruttererFase 2
- Mirador Therapeutics Selected Site, Tacoma
Crohns sykdom-studier i andre byer
- New York City, NY35 studier
- Boston, MA19 studier
- Miami, FL19 studier
- Cleveland, OH19 studier
- St. Louis, MO19 studier
- Tyler, TX17 studier
- Houston, TX17 studier
- Orlando, FL17 studier
- Atlanta, GA17 studier
- San Antonio, TX15 studier
- San Diego, CA15 studier
- Los Angeles, CA15 studier
Andre studier i Tacoma
- Ikke-småcellet lungekreft20 studier
- Brystkreft18 studier
- Ulcerøs kolitt15 studier
- Multipelt myelom13 studier
- Prostatakreft11 studier
- Kolorektal kreft9 studier
- Metastatisk kreft9 studier
- Melanom7 studier
- Eggstokkreft7 studier
- Mavekreft6 studier
- Spiserørkreft6 studier
- Kreft (alle typer)6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.